Another study established patient-derived xenograft (PDX) HCC models and proved that GPC3 CAR-T cells suppressed tumor growth but with varying efficacy due to different expressions of PDL1 on tumor cells (72). Here, GPC3 is linked to hepatocellular carcinoma.